---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020197"
form_type: "8-K"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:49:16.778819+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# FOXO Tech board approves spin-off of epigenetics subsidiary FOXO Labs

## Summary
- Board approved pursuing spin-off of FOXO Labs, Inc., its epigenetics subsidiary; FOXO shareholders to directly own shares in the new entity.
- FOXO will retain some ownership in the spun-off company while simplifying each entity's business model.
- FOXO Labs owns patent for machine learning model using DNA epigenetic data; focuses on saliva-based biomarker testing for health/longevity.
- Spin-off intended to create subscription-based revenue model for personal health and longevity coaching using AI and epigenetic analysis.

## SEC filing metadata
- accession: 0001641172-25-020197
- form_type: 8-K
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000164117225020197/0001641172-25-020197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000164117225020197/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020197
- JSON: https://secwatch.observer/filing/0001641172-25-020197.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020197.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.